Quince Therapeutics's total assets for Q4 2024 were $114.48M, a decrease of -9.52% from the previous quarter. QNCX total liabilities were $84.33M for the fiscal quarter, a 3.36% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.